辅助生殖技术 (ART) 市场 - 按类型、最终用户 - 全球预测

Assisted Reproductive Technology (ART) Market - By Type, End-User - Global Forecast

出版日期: 2024年05月09日 | 出版商:

Global Market Insights Inc. | 英文 125 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于受压力、年龄和环境变化等生活方式因素影响的不孕率上升，辅助生殖技术市场规模预计在 2024 年至 2032 年间将实现 6.9% 的复合年增长率。体外受精 IVF 和子宫内人工授精 IUI 等技术使个人和夫妇克服生育挑战。

辅助生殖技术 ART 方法被广泛开发，以提高成功率并最大限度地降低患者的风险。此外，新技术和改进方案的整合正在扩大辅助生殖技术的能力，为不孕症患者带来希望，进一步强化其作为生殖保健重要选择的作用。根据世界卫生组织的报告，全球约 17.5% 的成年人患有不孕症。这凸显了多种技术的迫切必要性，以扩大获得负担得起的高品质生育护理的机会。

ART 产业分为类型、最终用户/提供者和地区。

由于迫切需要帮助个人和夫妇透过解决生育挑战来实现为人父母的梦想，因此该产品类型细分市场的市场份额预计到 2032 年将大幅增长。 ART结合体外受精IVF、卵胞浆内单一精子显微注射ICSI等先进技术，提供更个人化、更有效的解决方案，并将基因筛检和创新治疗融为一体。随着研究人员不断发现提高成功率的新方法，ART 产品变得更加容易取得和精緻。

就最终用户/提供者而言，医院领域的辅助生殖技术市场预计将在 2024 年至 2032 年期间产生可观的收入。这受到了专家不断增长的需求的青睐，他们利用基因筛检和冷冻保存等技术来提高成功率和患者治疗效果。医院正在透过整合人工智慧和基因编辑等尖端创新来推进 ART，以提高诊断准确性和治疗效果，从而使生育治疗更加高效、侵入性更小。

受可支配收入增加以及用于提高这些服务品质和可及性的医疗保健投资激增的推动，到 2032 年，亚太地区辅助生殖技术行业规模可能会显着增长。政府和私营部门正在向医疗基础设施投入资源，以确保拥有最先进的设施和先进技术，从而促进区域市场的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 整个人群的不孕症盛行率不断上升
  - 人口结构转向接受辅助生殖技术 (ART)
  - 辅助生殖科技的科技进步
  - 人们对辅助生殖技术的认识不断提高
- 产业陷阱与挑战
  - 手续费用高
  - 新兴国家的社会障碍和缺乏先进的基础设施
成长潜力分析
技术景观
监管环境
定价分析，2021 - 2032
- 按地区分類的程序定价分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
产品
- 媒体
- 导管
- 针
- 玻璃化冷冻装置
- 孵化器
- 其他产品
程式
- 按类型
  - 新鲜捐赠者
  - 新鲜非捐赠者
  - 冷冻供体
  - 冷冻非捐赠者
- 依技术
  - 体外受精 (IVF)
    - IVF 胞浆内单一精子注射 (ICSI)
    - 无 ICSI 的 IVF
  - 人工授精 - 子宫腔内授精 (AI-IUI)

第 6 章：市场估计与预测：按最终用户/提供者划分，2021 - 2032 年

主要趋势
医院
生育诊所
其他最终用户/提供者

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 埃及
- 中东和非洲其他地区

第 8 章：公司简介

Esco Micro Pte. Ltd
Gynotec
Hamilton Thorne Ltd.
Indira IVF Hospital Private Limited
Ivy Fertility
Kitazato Corporation
Laboratoire CCD
Liverpool Partners Group
Merck KGaA
MISTRAL FERTILITY CLINICS S.L.
NidaCon International AB
Sumitomo Mitsui Financial Group, Inc.
The Cooper Companies, Inc.
Thermo Fisher Scientific Inc.
Vitrolife Group
Western Fertility Institute

简介目录

Product Code: 506

Assisted Reproductive Technology Market size is expected to record a 6.9% CAGR between 2024 and 2032, driven by rising infertility rates influenced by lifestyle factors, such as stress, age, and environmental changes. Technologies, including in vitro fertilization IVF and intrauterine insemination IUI are enabling individuals and couples to overcome fertility challenges.

Assisted reproductive technology ART methods are widely developed to enhance success rates and minimize risks for patients. Moreover, the integration of new technologies and improved protocols are expanding the capabilities of ART for providing hope for individuals struggling with infertility, further reinforcing its role as a vital option in reproductive healthcare. According to a report by WHO, around 17.5% of the adult population globally is experiencing infertility. This is underscoring the critical necessity for several technologies, to expand access to affordable and high-quality fertility care.

The ART industry is segmented into type, end-user/provider, and region.

The market share from the product type segment is expected to witness substantial growth through 2032 due to a strong need for helping individuals and couples achieve their dreams of parenthood by addressing fertility challenges. ART is incorporated with advanced techniques like in vitro fertilization IVF and intracytoplasmic sperm injection ICSI for offering more personalized and effective solutions as well as integrating genetic screening and innovative treatments. As researchers are discovering new ways to enhance success rates, ART products are becoming more accessible and refined.

In terms of end-user/provider, the assisted reproductive technology market from the hospitals segment is slated to generate notable revenue during 2024-2032. This is favored by rising demand by specialists who are utilizing techniques, such as genetic screening, and cryopreservation to improve success rates and patient outcomes. Hospitals are advancing ART by integrating cutting-edge innovations like AI and gene editing to enhance diagnostic accuracy and treatment efficacy for making fertility treatments more efficient and less invasive.

Asia Pacific assisted reproductive technology industry size is likely to record a notable growth rate through 2032 driven by rising disposable incomes along with surging healthcare investments for enhancing the quality and accessibility of these services. Governments and private sectors are pouring resources into healthcare infrastructure for ensuring state-of-the-art facilities and advanced technologies, adding to the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of infertility across population base
  - 3.2.1.2 Demographical shift towards acceptance of assisted reproductive technology (ART)
  - 3.2.1.3 Technological advancements in assisted reproductive technology
  - 3.2.1.4 Rising awareness regarding assisted reproductive technology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of procedures
  - 3.2.2.2 Social barriers and lack of advanced infrastructure in emerging countries
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2021 - 2032
- 3.6.1 Procedure pricing analysis, by region
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Product
- 5.2.1 Media
- 5.2.2 Catheters
- 5.2.3 Needles
- 5.2.4 Vitrification devices
- 5.2.5 Incubators
- 5.2.6 Other products
5.3 Procedure
- 5.3.1 By type
  - 5.3.1.1 Fresh donor
  - 5.3.1.2 Fresh nondonor
  - 5.3.1.3 Frozen donor
  - 5.3.1.4 Frozen nondonor
- 5.3.2 By technology
  - 5.3.2.1 In-vitro fertilization (IVF)
    - 5.3.2.1.1 IVF with intracytoplasmic sperm injection (ICSI)
    - 5.3.2.1.2 IVF without ICSI
  - 5.3.2.2 Artificial insemination - intrauterine insemination (AI-IUI)

Chapter 6 Market Estimates and Forecast, By End-User/Provider, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Fertility clinics
6.4 Other end-users/providers

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Egypt
- 7.6.3 Rest of Middle East and Africa